Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.
Popup heading
Close
Accessibility
Press enter for Accessibility for blind people
who use screen readers
Press enter for Keyboard Navigation
Press enter for Accessibility menu
×
Login
Subscribe
Log Out
Home Page
Jerusalem Post Conferences
Business & Innovation
Banking & Finance
Tech & Start Ups
Energy & Infrastructure
Real Estate
Opinion
JP Must
Precious Metals
Israel Real Estate
Aliyah
Environment & Climate Change
Premium
The Daily Edition
The Jerusalem Post Ivrit
The Jerusalem Report
Opinion
Real Estate Listings
JPost Store
Aliyah Portal
Elegance & Excellence
50 Influential Jews
Banking & Finance
Categories
Breaking News
Israel News
Israel Politics
Israel Culture
Israel Sports
World News
Islamic Terrorism
Middle East
Iran News
Isis Threat
Arab-Israeli Conflict
Gaza News
US Politics
Diaspora
Antisemitism
Opinion
Podcast
Judaism
Torah Portion
Jewish Holidays
List of holidays
Kabbalah
Christian World
Health & Wellness
Sleep
Mind & Spirit
Nutrition
Coronavirus
Exercise
Pregnancy & Birth
Parenting
Supplements
Science
Law
Archaeology
OMG
Antisemitism
Food & Recipes
Jerusalem Post en Español
History
Sponsored Content
Advertise With Us
Terms of Use
Privacy Policy
Contact Us
Cancel Subscription
Customer Service
About Us
Advertisement
Pharmaceuticals
Israel’s healthcare workforce lags behind OECD averages despite growth in doctors and nurses
By Avihai Chiim
Teva share price struggles to recover following $6 billion market loss
By Shiri Habib-Valdhorn/Globes/TNS
Israel on the pharma frontier: How AION Labs is incubating the next drug development breakthrough
By JERUSALEM POST STAFF
Immunai and Teva partner to innovate new cancer, immunology therapies
By Raquel Guertzenstein Frohlich
Israeli mapping company ImmunAI partners with AstraZeneca
By MAARIV
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
By JERUSALEM POST STAFF
Kahun’s pharma-focused AI agent: Bridging medical knowledge and patient care
By ARIEL SHAPIRA
Mounjaro: the next big thing in weight loss, now heading to Israel
By DR. ITAY GAL
Israel set to start selling pharmaceuticals outside of pharmacies
By DR. ITAY GAL
We must change the prejudices of mainstream medicine against lifestyle intervention
By ALAN FREISHTAT
Pharma companies challenge lawsuit alleging terrorism funding activities in US Supreme Court
By REUTERS
Teva joins world’s top 20 pharmaceutical companies
By JUDY SIEGEL-ITZKOVICH
Medical hotline to assist patients and professionals reopens in Israel
By JUDY SIEGEL-ITZKOVICH
The growth strategy of the Be Pharm chain: opens 3 new branches
By Lee Sivilia
New appointments in L'Oréal Israel's senior management avenue
By Dana Oz
Nonprofit pharmacy organization provides free medication to evacuees
By JUDY SIEGEL-ITZKOVICH
Use of medications for anxiety, sleep problems and depression increasing since the war began
By JUDY SIEGEL-ITZKOVICH
Two Bar-Ilan University researchers receive NIS 14m. in grants
By JUDY SIEGEL-ITZKOVICH
1
2
>
Advertisement